Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments
Sign Up to like & getrecommendations! Published in 2021 at "IDCases"
DOI: 10.1016/j.idcr.2021.e01111
Abstract: We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found than iatrogenic immunosuppression and COVID-19 immune dysregulation.… read more here.
Keywords: complication covid; cytomegalovirus proctitis; covid immunosuppressive; covid ... See more keywords
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0184398
Abstract: Background Immunosuppressive agents in general are shown to prevent renal progression and all-cause mortality in idiopathic membranous nephropathy (IMN) patients with nephrotic syndrome. However, the efficacy and safety of different immunosuppressive treatments have not been… read more here.
Keywords: network meta; immunosuppressive treatments; meta analysis;
Cerebral toxoplasmosis associated with the use of immunosuppressive treatments
Sign Up to like & getrecommendations! Published in 2022 at "Revista da Sociedade Brasileira de Medicina Tropical"
DOI: 10.1590/0037-8682-0720-2021
Abstract: FIGURE 2: The lesion partially calcified without significant postcontrast enhancement in the left striatocapsular region. The reduction of the edema component, which does not currently extend to the temporal lobe, is more evident in T2… read more here.
Keywords: cerebral toxoplasmosis; immunosuppressive treatments; toxoplasmosis; associated use ... See more keywords